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Histone deacetylases affect transcriptional regulation of CCL2  
and CXCL8 expression by pulmonary fibroblasts in vitro
Epigenetic regulation of CCL2 and CXCL8 expression
Abstract 
Introduction: Chemokines have been shown to play an important role in tissue remodeling and fibrosis in the respiratory system. In this 
study we wanted to evaluate the mechanisms, which regulate the expression of selected chemokines by pulmonary fibroblasts in vitro. 
Material and methods: Pulmonary fibroblasts were cultured with and without bacterial lipopolysaccharide (LPS) for 6 hours. In 
addition some of the cultures were pre-treated with histone deacetylase inhibitor Trichostatin A (TSA). Real-time PCR reaction 
was performed to estimate the expression of chemokines CCL2, CCL3 and CXCL8.
Results: In unstimulated cultures detectable expression of CCL2 and CXCL8 was observed, while CCL3 expression could not be 
detected. After stimulation with LPS, TSA and both agents together CCL2 expression rose by 1.52, 1.62 and 1.8 times in compa-
rison to control cultures respectively. CXCL8 mRNA expression levels after stimulation with LPS, TSA and LPSTSA increased by 
1.53, 1.91 and 2.4 times accordingly. 
Conclusion: Epigenetic mechanisms related to histone acetylation affects transcriptional regulation of CCL2 and CXCL8 expres-
sion by pulmonary fibroblasts. Those mechanisms may play a role in tissue repair and pathologic remodeling.
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Introduction
Fibroblasts are involved in tissue repair after 
injury, but in chronic pathologic conditions they 
are responsible for remodeling such as excessive 
fibrosis, which leads to irreversible impairment 
of organ functions [1]. It is particularly important 
in the respiratory system where fibrotic processes 
participate in obstructive and restrictive lung di-
seases [2]. Both conditions lead to lung function 
impairment and finally respiratory failure and 
death. In fact, chronic obstructive pulmonary 
disease and pulmonary fibrosis are leading causes 
of morbidity and mortality due to chronic respira-
tory diseases [3]. Fibroblasts themselves actively 
participate in regulation of inflammatory response 
and tissue repair by secretion of a broad array of 
biologically active mediators such as cytokines 
and chemokines [4]. 
Fibroblasts represent a heterogeneous popu-
lation of cells, which differ in their pro-fibrotic 
potential and the profile of released mediators 
[5]. Residing in different organs fibroblasts adjust 
their phenotype and function [6]. Several studies 
demonstrated that fibroblasts from different or-
gans may differ in their ability to produce biolo-
gically active mediators [7–9]. Similarly, different 
pathologic conditions may lead to changes in 
fibroblast phenotype, the most pronounced being 
the transformation of fibroblasts into myofibro-
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blasts seen in chronic inflammatory diseases such 
as asthma [10]. The altered fibroblast phenotypes 
are manifested not only in vivo but also ex vivo, 
as demonstrated in cell culture experiments [11]. 
The persistence of altered fibroblast phenotype ex 
vivo indicates that some genetic and/or epigenetic 
mechanisms may be involved in this process. The 
mechanisms leading to altered fibroblast pheno-
type may affect the profile of biologically active 
mediators released by individual cells. 
Among chemokines produced by fibroblasts 
and involved in the process of tissue remodeling 
and fibrosis CCL2 and CXCL8 are of particular 
interest. It has been already demonstrated that 
CCL2 plays a crucial role in the process of tissue 
fibrosis in chronic diseases which are characteri-
zed by excessive fibrosis, such as systemic sclero-
sis [12]. In patients with systemic sclerosis CCL2 
is overexpressed by fibroblasts derived from the 
skin [12]. Moreover, ex vivo elevated production 
of CCL2 by peripheral blood mononuclear cells 
derived from systemic sclerosis patients has also 
been demonstrated [13]. In addition exacerbation 
of chronic diseases such as allergic asthma is 
associated with increase of plasma CCL2 con-
centration [14]. 
Fibroblasts are also a major source of CXCL8 
in chronic pulmonary diseases [15]. Fibroblasts 
derived from the airways of chronic obstructive 
airway disease (COPD) patients release more 
CXCL8 upon stimulation with WNT-5 ligands 
than those from healthy subjects [16]. Elevated le-
vels of CXCL8 are produced by fibroblasts derived 
from tissues undergoing pathological remodeling. 
In particular, fibroblasts from nasal polyps rele-
ase more CXCL8 than those from nasal mucosa 
derived from patents without nasal polyps [17]. 
Moreover, human lung fibroblasts release CXCL8 
and CCL2 upon stimulation with Mycoplasma 
antigens indicating that those chemokines are 
involved in innate immune response [18]. 
Regulation of the CCL2 expression by diffe-
rent cells has been demonstrated on genetic and 
epigenetic levels [19–22]. Association of genetic 
polymorphisms which alter CCL2 expression with 
different pathological processes have been already 
demonstrated [19, 20]. Among genetic factors an 
A-2578G single nucleotide polymorphism, which 
is functional and affects the expression of CCL2 
is associated with susceptibility to some chronic 
diseases such as asthma or lupus nephritis [19, 
20]. Moreover, altered histone acetylation plays 
a role in the regulation of CCL2 expression indi-
cating on an important role of epigenetic factors 
on CCL2 expression [21]. Similarly, functional 
polymorphisms of CXCL8 and its receptor has 
been shown to confer predisposition to systemic 
sclerosis [22]. 
The aim of this study was to evaluate mecha-
nisms, which regulate the expression of chosen 
chemokines in vitro by pulmonary fibroblasts.
Material and methods
Cell culture: Human lung fibroblast cell 
line HLF 506-05a derived from normal human 
lung parenchyma was obtained from American 
Type Culture Collection (ATCC) and cultured in 
Dulbecco Modified Eagle Medium (DMEM) with 
sodium pyruvate, L-glutamine and 3.7 g/L sodium 
bicarbonate (PAN-Biotech, Aidenbach, Germany) 
supplemented with 10% Fetal Bovine Serum (Sig-
ma-Aldrich St Louis, MO, USA), Penicillin (100 U/
ml), Streptomycin (0.1 mg/ml) (Sigma-Aldrich, St. 
Louis, MO, USA), 5% MEM Non-Essential Amino 
Acids Solution (Gibco, ThermoFisher Scientific, 
Waltham, MA, USA) and 0.5% 2-mercaptoetha-
nol (Sigma-Aldrich). In addition, obtained from 
ATCC, human gingival fibroblasts cell line HGF-1 
was used as a comparator. Preliminary culture 
was carried out under normal air conditions in 
a 5% carbon dioxide atmosphere at 37°C in cell 
culture flasks for adherent cells. After incubation 
for 20 hours with or without Trichostatin A (Sig-
ma-Aldrich) at a concentration of 250 nM the 
cells were stimulated with 2.5 mg/ml bacterial 
endotoxin (Sigma-Aldrich) for 6 hours. After the 
stimulation the cells were lysed in RA1 buffer, 
collected with the use of RNAlater (Sigma-Al-
drich) and frozen in –80°C until tested.
RNA isolation: Isolation of RNA was per-
formed on the frozen cells lysate with the use 
of the NucleoSpin® RNA II Kit according to 
manufacturer protocol. Quality, purity and con-
centration of isolated RNA was evaluated with 
spectrophotometric method on NanoDrop 2000.
Reverse transcription: Reverse transcription 
reaction was performed with High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, 
Carlsbad, CA, USA) according to the manu-
facturer protocol. The PCR amplification was 
carried out in 10 μL reaction mix consisting of 
MultiScribe™ Reverse Transcriptase 0.5 μL, 25 × 
dNTP Mix (100 mM) 0.4 μL, 200ng of tested RNA 
and 1 μL of both primers and RT buffer supplied 
by the manufacturer. Reactions were performed 
with the use of recommended by the manufac-
turer thermal cycling conditions.
Gene expression estimation: To estimate 
expression profiling for selected genes, real-time 
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RT-PCR analysis was performed as described 
previously. We report data for gene-expression 
TaqMan assays for CCL2 (NM_002982), CCL3 
(NM_002983) and CXCL8 (NM_000584.3). 
The relative expression of target mRNA was 
normalized to the housekeeping gene of 
b-2-microglobulin (NM_002982.3).
Quantitative estimation of gene expression: 
To estimate the relative expression level (R) of 
tested genes we used DDCT comparative analysis. 
As an endogenous and exogenous control was 
used expression level of b-2-microglobulin gene 
and expression levels of unstimulated samples 
accordingly. In the first step we calculated DCT 
between tested genes and endogenous control. 
Next we computed DDCT between stimulated and 
unstimulated samples and calculated relative 
expression levels between both samples.
Statistical analysis: Statistical analysis and 
graphs were done in Medcalc. Results are present-
ed as median ± interquartile ranges (IQR). MRNA 
expression levels of each chemokine were cal-
culated as the percentage of endogenous control 
mRNA level. Results were obtained through cal-
culation of DCT. Statistical evaluation of obtained 
results was executed with the Kruskal-Wallis test. 
Evaluation of differences between tested cytokines 
was performed with the use of Wilcoxon test.
Results
In the unstimulated lung fibroblasts the great-
est expression among the studied chemokines was 
detected for CXCL8 (DCT = 0.313; 0.228–0.435), 
which was significantly greater than that of CCL2 
(DCT = 0.174; 0.084–0.435; p < 0.05) (Fig. 1). 
Comparing the numerical values of basal mRNA 
expression the expression of CXCL8 was almost 
twice as high as the expression of CCL2. In vitro 
expression of CCL3 in pulmonary fibrobasts was 
not detected after 40 cycles of PCR amplification. 
In contrast to the lung fibroblasts, significant 
expression of CCL3 (DCT = 0.16; 0.07–0.35) 
was detected in the gingival fibroblasts which 
was comparable to that of CCL2 (DCT = 0.22; 
0.12–0.35; p = 0.2) and less than that of CXCL8 
(DCT = 0.425; 0.3–0.54; p < 0.01). 
In order to evaluate potential effect of activa-
tion status on differences in individual chemok-
ine expression between lung and gingival fibro-
blasts the former cells were stimulated with LPS. 
Moreover, to evaluate a potential effect of histone 
acetylation on specific pattern of chemokine ex-
pression by lung fibroblasts was evaluated. 
Stimulation with LPS resulted in significant 
up-regulation of CCL2 and CXCL8 and no effect 
on CCL3 expression by the lung fibroblasts. 
In vitro expression level of CCL2 mRNA in 
stimulated by LPS pulmonary fibroblast cultures 
was 1,52 fold greater than in the control cultures 
(1.122–1.838; p < 0.05) and it was similar to 
that in cultures stimulated by TSA where CCL2 
expression was 1,62 fold greater than in the con-
trol cultures (1,5–1,805; p = 0.4) (Fig. 2). Stim-
ulation of TSA pre-treated lung fibroblasts with 
LPS resulted in 1.8 fold (1.55–2.1) increase of 
Figure 1. mRNA expression of chosen cytokines in unstimulated cultures of pulmonary (open bars) and gingival (gray bars) fibroblasts
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Figure 2. Changes of CCL2 (empty bars) and CXCL8 (gray bars) expression in response to LPS and/or TSA stimulation. Only significant differences 
are marked
CCL2 expression in comparison to unstimulated 
cultures. The effect was slightly greater than 
that of LPS alone (p < 0.05) but did not differ 
significantly from that seen in TSA stimulated 
cultures (p = 0.1). 
Pulmonary fibroblasts stimulated with LPS 
were characterized by 1.53 fold (1.28–2.15) 
greater CXCL8 than in the control cultures (p < 
0.01). In the cells treated with TSA the expression 
of CXCL8 was higher (1.91 fold; 1.78–2.16) and 
it was significantly greater that in the control 
cultures (p < 0.01) being also greater than in 
the cells stimulated with LPS alone (p < 0.05). 
Concomitant treatment of pulmonary fibroblasts 
with TSA and LPS resulted in 2.41 fold (2.1–2.53; 
p < 0.01) up-regulation of CXCL8 expression 
(Fig. 2) which indicates the additive effect of 
individual stimuli. 
Discussion 
Our study demonstrates in vitro differences 
in a pattern of CCL2, CXCL8 and CCL3 mRNA 
expression by fibroblasts derived from different 
anatomical localizations with a special attention 
to pulmonary fibroblasts. The results indicates 
on differences in transcriptional regulation of 
individual chemokines in relation to the site of 
origin of individual fibroblasts. Interestingly, we 
demonstrated the lack of CCL3 expression in the 
lung fibroblasts both spontaneously and after 
stimulation with endotoxin. However, CCL2 and 
CXCL8 were expressed and the level of their 
expression was significantly up-regulated after 
LPS stimulation. This is coherent with the study 
results of Daenga et al. [23] in which endogenous 
expression of CCL2 mRNA in pulmonary fibro-
blasts derived from healthy subjects was demon-
strated and significantly higher expression of this 
chemokine mRNA levels in pulmonary fibroblasts 
of people with idiopathic pulmonary fibrosis was 
detected [23]. Similarly, another study demonstra-
ted significant expression of CXCL8 by pulmonary 
fibroblasts [24]. Finally, the lack of basal expres-
sion of CCL3 mRNA in pulmonary fibroblasts is 
coherent with the study of Brouty-Boyé et al. [25] 
in which CCL3 expression by bone marrow and 
breast, but not pulmonary fibroblasts was detec-
ted [25]. All this studies provided evidence for 
functional heterogeneity of fibroblasts derived 
from the lungs and gingiva. 
Since differences in CCL3 mRNA expression 
between pulmonary and other fibroblasts could 
potentially indicate differences in epigenetic 
control we decided to evaluate the effect of TSA 
on expression of the studied chemokines. Our 
study did not support the concept which assu-
med that histone acetylation played a major role 
in regulation of CCL3 expression. It seems that 
more stable mechanisms of CCL3 gene repression 
operate in pulmonary fibroblasts. 
Moreover, we were able to demonstrate no 
additive effect of TSA on LPS-stimulated CCL2 
expression which again argue against little role 
Paweł Golec et al., Histone deacetylases affect transcriptional regulation of CCL2 and CXCL8 expression
311www.journals.viamedica.pl
of histone acetylation in the expression of that 
chemokine by pulmonary fibroblasts. Most of 
the CC chemokines, including CCL2 and CCL3 
are clustered on a  long arm of chromosome 17 
(17q11.2–q21.1) which indicates that similar 
level of histone acetylation in that region may 
be seen. Interestingly, in other cell types additive 
effect of TSA on LPS-stimulated CCL2 expression 
was observed [26, 27]. The additive effects were 
demonstrated for murine preadipocytes and 
macrophages [26, 27]. On the other hand inhibi-
tory effect on CCL2 expression was detected in 
aortic endothelial cells [28]. The results of the 
presented studies indicate that cells from various 
anatomical regions and tissues differently react 
to hiperacethylation of histone tails inducted by 
TSA and a small amount of studies typify this 
occurrence does not allow to place unequivocal 
conclusions.
In contrast to CC chemokines we were able to 
demonstrate a significant effect of TSA on expres-
sion of CXCL8 both spontaneously and after LPS 
stimulation. These results indicate an addictive 
influence of histone tail acetylation induced by 
TSA with LPS-induced cell activation on CXCL8 
mRNA expression in pulmonary fibroblast ex 
vivo. Similar results were obtained by Iwata et 
al. who observed growth of CXCL8 expression 
in lung epithelial cells transformed with SV-40 
stimulated by LPS and TSA in comparison to 
those cells stimulated by LPS alone [29]. Angri-
sano et al. [30] received also congruous results 
using human derived colon cells. Angrisano 
and coworkers observed increased expression 
of CXCL8 mRNA in cultures stimulated by LPS 
and TSA in comparison to stimulation with LPS 
alone and also noted differences in acetylation 
and methylation of histone tails in CXCL8 gene 
promoting region after stimulation with LPS [30]. 
Interestingly, CXCL8 is localized on the long arm 
of chromosome 4 (4q13.3) and therefore local 
differences in histone acetylation may explain 
the differences of TSA effect on CCL2 and CXCL8 
expression. 
Therefore, therapeutic agents which affect 
histone acetylation may exert different effect 
on the expression of individual chemokines in 
pulmonary fibroblasts. Also, the effect of those 
therapeutic agents may differ depending on the 
anatomical localization of fibroblasts. It should 
be emphasized however, that in this study we 
focused only on a one mechanism of epigenetic 
control of chemokine expression. It is likely 
that other epigenetic and genetic factors may 
affect expression of those chemokines in clinical 
practice. Further studies are warranted to solve 
the mechanisms responsible for regulation of 
fibroblast phenotypes. This may be particularly 
important in search for effective treatment of 
diseases which are characterized by pathological 
tissue remodeling with fibrosis such as pulmo-
nary fibrosis and COPD. 
Conclusions
In summary, our study demonstrates the 
complex regulation of chemokine expression by 
pulmonary fibroblasts. It indicates the differenc-
es between epigenetic regulation of CXCL8 and 
CCL2/CCL3 expression indicating on a possible 
role of pulmonary fibroblasts as a  source of 
pro-inflammatory chemokines CCL2 and CXCL8 
in the pathogenesis of chronic inflammatory lung 
diseases. 
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